95 related articles for article (PubMed ID: 6244997)
1. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
[TBL] [Abstract][Full Text] [Related]
2. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
van der Marel P; Hazendonk AG; van Wezel AL
Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
Moynihan M; Ladefoged P; Mathiesen L
Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
5. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
Glikmann G; Moynihan M; Petersen I; Vestergaard BF
Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
[TBL] [Abstract][Full Text] [Related]
6. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
Rezapkin G; Dragunsky E; Chumakov K
Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of poliovirus antigen measurements in vitro and in small animals.
von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
[No Abstract] [Full Text] [Related]
8. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
9. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
10. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
Gu FZ; Wang SH; Sun YY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
[No Abstract] [Full Text] [Related]
11. Measuring Poliovirus Antigenicity by Surface Plasmon Resonance. Application for Potency Indicating Assays.
Westdijk J; van der Maas L; Ten Have R; Kersten G
Methods Mol Biol; 2016; 1387():299-323. PubMed ID: 26983742
[TBL] [Abstract][Full Text] [Related]
12. Development of inactivated poliovirus vaccine derived from Sabin strains.
Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
[TBL] [Abstract][Full Text] [Related]
13. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
Jiang SD; Pye D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
[No Abstract] [Full Text] [Related]
14. Diffusion-in-gel enzyme-linked immunosorbent assay (DIG-ELISA). Quantification of antigen by diffusion over an antibody-coated surface.
Nygren H; Stenberg M
Scand J Clin Lab Invest; 1982 Jun; 42(4):355-9. PubMed ID: 6813949
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine and its safety].
Bian CX; Jiang SD; Yang JY; Sun MB; Xie MX; Zhang XW; Liao GY; Li WD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):44-6. PubMed ID: 17429533
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
[TBL] [Abstract][Full Text] [Related]
17. [Demonstration of Newcastle disease virus by enzyme-linked immunosorbent assay].
Dumanova L; Vasileva L; Chenchev I
Vet Med Nauki; 1982; 19(3):46-51. PubMed ID: 6814046
[TBL] [Abstract][Full Text] [Related]
18. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of poliovirus with beta-propiolactone.
Jiang SD; Pye D; Cox JC
J Biol Stand; 1986 Apr; 14(2):103-9. PubMed ID: 3020055
[TBL] [Abstract][Full Text] [Related]
20. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P
Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]